This topic contains a solution. Click here to go to the answer

Author Question: A patient is diagnosed with peptic ulcer disease complicated by H. pylori. What is the rationale for ... (Read 94 times)

aabwk4

  • Hero Member
  • *****
  • Posts: 593
A patient is diagnosed with peptic ulcer disease complicated by H. pylori. What is the rationale for adding bismuth to the patient's medication regimen?
 
  A) Increases pepsin activity
  B) Decreases gastrin secretion
  C) Prevents metabolic alkalosis
  D) Protects gastric mucosa from stomach acid

Question 2

A patient's current drug regimen includes intranasal administration of desmopressin acetate (DDAVP, Stimate). In this patient's plan of nursing care, what is the most likely desired outcome of treatment?
 
  A) The patient's urine output will not exceed 80 mL/h.
  B) The patient will gain 2 cm in height over the next 6 months.
  C) The patient will ovulate at least once over the next 8 weeks.
  D) The patient's vertical growth will cease in the next 4 weeks.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

coreycathey

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

D
Feedback:
Health care providers use bismuth subsalicylate to coat ulcers, protecting them from stomach acid to treat H. pylori. Bismuth does not increase pepsin activity, decrease gastrin secretion, or prevent metabolic alkalosis.

Answer to Question 2

A
Feedback:
Desmopressin acetate (DDAVP, Stimate) is the prototype posterior pituitary hormone medication. It is used to treat diabetes insipidus. Consequently, reduced urine output is the primary goal of treatment. The drug does not influence growth or ovulation.




aabwk4

  • Member
  • Posts: 593
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


lcapri7

  • Member
  • Posts: 350
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

For a complete list of videos, visit our video library